Dr. Juan German Miranda, MD

Dr. Miranda practices at Hospital Menonita Guayama in Guayama, Puerto Rico, part of Menonita Health System.

Dr. Miranda's NPI, 1356419469, was assigned on November 30, 2006. Dr. Miranda holds Puerto Rico license 8514.

Dr. Miranda's primary practice is Hospital Menonita Guayama, at Ave. Pedro Albizu Campos Urb. La Hacienda, Guayama, PR 00785 in Guayanilla County. The practice phone is (787) 864-4300. The NPI Registry lists Dr. Miranda's practice address as 14 Cll 2, Guaynabo, PR 00969.

Dr. Miranda's primary practice is Hospital Menonita Guayama in Guayama, Puerto Rico, part of Menonita Health System. The medical group on file is Hospital Menonita Guayama.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miranda practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Miranda's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Miranda is licensed in Puerto Rico.

CMS data shows 81 Medicare services from Dr. Miranda across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $4,025 for them. Every service was in an office.

CMS counts 28 Medicare patients who saw Dr. Miranda in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miranda's median patient age at 76, with 33% women.

In 2024, Dr. Miranda wrote 3,076 Medicare Part D claims for 394 patients. 82% of them were for generic drugs. CMS names the drug for 2,759 of them, across 58 drugs with 11 or more claims each, at $322,222 in total drug cost. In 2023, CMS named 2,742 claims across 57 drugs.

Dr. Miranda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 71 general payments to Dr. Miranda from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $594.